These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6447834)

  • 1. Proliferation of T gamma cells with killer-cell activity in patients with neutropenia.
    Ceuppens J
    N Engl J Med; 1980 Oct; 303(15):882. PubMed ID: 6447834
    [No Abstract]   [Full Text] [Related]  

  • 2. Proliferation of T gamma cells with killer-cell activity in patients with neutropenia.
    Brouet JC
    N Engl J Med; 1980 Oct; 303(15):882. PubMed ID: 6968035
    [No Abstract]   [Full Text] [Related]  

  • 3. Proliferation of T gamma cells with killer-cell activity in two patients with neutropenia and recurrent infections.
    Bom-van Noorloos AA; Pegels HG; van Oers RH; Silberbusch J; Feltkamp-Vroom TM; Goudsmit R; Zeijlemaker WP; von dem Borne AE; Melief CJ
    N Engl J Med; 1980 Apr; 302(17):933-7. PubMed ID: 6444696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of T gamma cells with killer-cell activity in patients with neutropenia.
    Ault KA; Smith BR; Holmberg LA
    N Engl J Med; 1980 Oct; 303(15):881-2. PubMed ID: 6968034
    [No Abstract]   [Full Text] [Related]  

  • 5. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
    Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
    Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stem cell inactivation by allogenic lymphocytes: characteristics of suppressor cells blocking the killer action of syngeneic lymphocytes].
    Ignat'eva GA; Man'ko VM; Dishkant IP
    Tsitologiia; 1981 Dec; 23(12):1386-94. PubMed ID: 6460363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited effect of eicosapentaenoic acid on T-lymphocyte and natural killer cell numbers and functions in healthy young males.
    Miles EA; Banerjee T; Wells SJ; Calder PC
    Nutrition; 2006 May; 22(5):512-9. PubMed ID: 16600816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diversity and pathology of lymphocytes].
    Govaerts A
    Rev Med Brux; 1982 Apr; 3(4):235-6. PubMed ID: 6211756
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.
    Ghiringhelli F; Ménard C; Martin F; Zitvogel L
    Immunol Rev; 2006 Dec; 214():229-38. PubMed ID: 17100888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells.
    Uchiyama T; Nelson DL; Fleisher TA; Waldmann TA
    J Immunol; 1981 Apr; 126(4):1398-403. PubMed ID: 6451645
    [No Abstract]   [Full Text] [Related]  

  • 12. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro immunosuppressive effect of 8-amino-9-benzylguanine on lymphocytes.
    Yen CY; Lin CY; Yu DS
    Transplant Proc; 1994 Aug; 26(4):1910-2. PubMed ID: 8066622
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular mechanisms of antibody production.
    Wieczorek Z
    Acta Histochem Suppl; 1980; 22():19-26. PubMed ID: 6454903
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of natural killer activity and antibody-dependent cellular cytotoxicity by cultured human lymphocytes.
    Nair MP; Schwartz SA
    J Immunol; 1981 Jun; 126(6):2221-9. PubMed ID: 6453160
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiotherapy and antitumor immunity. Fundamentals of immunooncology].
    Klimovich VB
    Med Radiol (Mosk); 1982 Jun; 27(6):68-73. PubMed ID: 6213829
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: gammadelta T lymphocytes and natural killer cells.
    Malkovsky M; Wallace M; Fournié JJ; Fisch P; Poccia F; Gougeon ML
    AIDS; 2000; 14 Suppl 3():S175-86. PubMed ID: 11086860
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the role of natural killer cells in Listeria monocytogenes infection: relation between natural killer cells and T-cell receptor gamma delta T cells in the host defence mechanism at the early stage of infection.
    Takada H; Matsuzaki G; Hiromatsu K; Nomoto K
    Immunology; 1994 May; 82(1):106-12. PubMed ID: 8045587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of interleukin-2 treatment on CD1d-restricted natural killer T cells.
    Sandberg JK; Moll M
    Clin Cancer Res; 2007 Jul; 13(14):4311; author reply 4311-2. PubMed ID: 17634562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.